Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,293.50
+0.70 (0.05%)
Feb 18, 2026, 3:20 PM IST
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 3.91 billion as of February 18, 2026. Its market cap has increased by 2.52% in one year.
Market Cap
3.91B
Enterprise Value
4.75B
Revenue
3.48B
Ranking
n/a
PE Ratio
19.69
Stock Price
1,293.50
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 3.91B, an increase of 858.69%. That is a compound annual growth rate of 30.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 3.91B | -2.36% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 615.55B |
| Anthem Biosciences | 387.45B |
| OneSource Specialty Pharma | 137.27B |
| Concord Biotech | 121.75B |
| Blue Jet Healthcare | 62.03B |
| Supriya Lifescience | 54.19B |
| Zota Health Care | 46.49B |
| Dishman Carbogen Amcis | 30.82B |